Context
From 2015 to 2017 I was Product Director at System C Healthcare, responsible for three electronic health record products — Medway, CareFlow and Graphnet — serving more than 300,000 users, with P&L responsibility for multi-million-pound product lines.
System CAcquisition of The Learning ClinicAcquisition of CareFlow
What the real problem was
System C supported a wide range of services across the NHS: secondary, primary, community and social care, each with its own workflows, governance and buyers. This was a complex B2B enterprise problem. We had to win new business through long procurement cycles while continuing to meet the needs of existing customers running our products every day.
At the same time, clinical work was moving away from the desk. Most hospitals were still pushing “computers on wheels” between beds, and clinicians and nurses needed patient data in their hands.
What happened
Mobile at the bedside: I led the acquisition and integration of two mobile health products, VitalPak and CareFlow, bringing patient data to clinicians and nurses where care happens.
Electronic prescribing: I launched an electronic prescribing product across multiple health systems, connecting to the NHS Spine and integrating with e-prescribing services.
Modernisation: I led the roadmap for re-architecting our infrastructure and products on Microsoft Azure, to support rapid deployment, continuous integration and simpler maintenance.
Leading at scale: I managed nine product managers and coordinated across more than 200 engineering, design and specialist roles, at one of the largest UK-based healthcare software providers.
What I would do differently
The hardest part of the role was balancing customer demand, sales demand and a technical roadmap to modernise the portfolio. In the end we invested in modernisation, because it was what would make deployment and sales cycles faster, let us bring new propositions into the portfolio and support cross-selling across the business.
Given the chance again, I would make the same decision. What I would change is how closely we worked with customers through it: explaining earlier and more directly why some things were delayed, and what they would gain as a result.




